- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Obstetrics and Gynecology International
Volume 2011 (2011), Article ID 949302, 6 pages
Effect of Red Clover Isoflavones over Skin, Appendages, and Mucosal Status in Postmenopausal Women
1Division of Obstetrics and Gynecology, General Public Teaching Hospital Korneuburg, 2100 Korneuburg, Austria
2Instituto para la Salud de la Mujer, Facultad de Ciencias Médicas, Universidad Católica de Santiago Guayaquil, 196 Guayaquil, Ecuador
3Study Center Med XIX, Grinzingerstr 83, 1190 Vienna, Austria
4Division of Obstetrics and Gynecology, Medical University of Vienna, 1090 Vienna, Austria
Received 7 August 2011; Accepted 31 August 2011
Academic Editor: Faustino R. Pérez-López
Copyright © 2011 Markus Lipovac et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- M. Imhof, A. Gocan, F. Reithmayr et al., “Effects of a red clover extract (MF11RCE) on endometrium and sex hormones in postmenopausal women,” Maturitas, vol. 55, no. 1, pp. 76–81, 2006.
- S. Geller and L. Studee, “Soy and red clover for mid-life and aging,” Climacteric, vol. 9, no. 4, pp. 245–263, 2006.
- E. Barrett-Connor, D. Grady, and M. L. Stefanick, “The rise and fall of menopausal hormone therapy,” Annual Review of Public Health, vol. 26, pp. 115–140, 2005.
- North American Menopause Society, “Treatment of menopause associated vasomotor symptoms: position statement of the North American Menopause Society,” Menopause, vol. 11, no. 1, pp. 11–33, 2004.
- V. Beck, U. Rohr, and A. Jungbauer, “Phytoestrogens derived from red clover: an alternative to estrogen replacement therapy?” Journal of Steroid Biochemistry and Molecular Biology, vol. 94, no. 5, pp. 499–518, 2005.
- K. M. Jordan and C. Cooper, “Epidemiology of osteoporosis,” Best Practice and Research: Clinical Rheumatology, vol. 16, no. 5, pp. 795–806, 2002.
- A. H. Roudsari, F. Tahbaz, A. Hossein-Nezhad, B. Arjmandi, B. Larijani, and S. M. Kimiagar, “Assessment of soy phytoestrogens' effects on bone turnover indicators in menopausal women with osteopenia in Iran: a before and after clinical trial,” Nutrition Journal, vol. 4, p. 30, 2005.
- X. Zhang, X. O. Shu, H. Li et al., “Prospective cohort study of soy food consumption and risk of bone fracture among postmenopausal women,” Archives of Internal Medicine, vol. 165, no. 16, pp. 1890–1895, 2005.
- M. T. Goodman, L. R. Wilkens, J. H. Hankin, L. C. Lyu, A. H. Wu, and L. N. Kolonel, “Association of soy and fiber consumption with the risk of endometrial cancer,” American Journal of Epidemiology, vol. 146, no. 4, pp. 294–306, 1997.
- P. L. Horn-Ross, E. M. John, A. J. Canchola, S. L. Stewart, and M. M. Lee, “Phytoestrogen intake and endometrial cancer risk,” Journal of the National Cancer Institute, vol. 95, no. 15, pp. 1158–1164, 2003.
- W. H. Xu, W. Zheng, Y. B. Xiang et al., “Soya food intake and risk of endometrial cancer among Chinese women in Shanghai: population based case-control study,” British Medical Journal, vol. 328, no. 7451, pp. 1285–1288, 2004.
- S. M. Boyapati, X. O. Shu, X. R. Zhi et al., “Soyfood intake and breast cancer survival: a followup of the Shanghai Breast Cancer Study,” Breast Cancer Research and Treatment, vol. 92, no. 1, pp. 11–17, 2005.
- B. N. Fink, S. E. Steck, M. S. Wolff et al., “Dietary flavonoid intake and breast cancer survival among women on long island,” Cancer Epidemiology Biomarkers and Prevention, vol. 16, no. 11, pp. 2285–2292, 2007.
- C. B. Tempfer, E. K. Bentz, S. Leodolter et al., “Phytoestrogens in clinical practice: a review of the literature,” Fertility and Sterility, vol. 87, no. 6, pp. 1243–1249, 2007.
- K. Morito, T. Aomori, T. Hirose et al., “Interaction of phytoestrogens with estrogen receptors alpha and beta (II),” Biological & Pharmaceutical Bulletin, vol. 25, no. 1, pp. 48–52, 2002.
- N. L. Booth and C. E. Piersen, “Red Clover (Trifolium pratense),” Encyclopedia of Dietary Supplements, pp. 587–602, 2006.
- E. M. Umland, “Treatment strategies for reducing the burden of menopause-associated vasomotor symptoms,” Journal of Managed Care Pharmacy, vol. 14, no. 3, pp. S14–S19, 2008.
- C. Atkinson, J. E. Compston, N. E. Day, M. Dowsett, and S. A. Bingham, “The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial1-3,” American Journal of Clinical Nutrition, vol. 79, no. 2, pp. 326–333, 2004.
- M. Lipovac, P. Chedraui, C. Gruenhut, A. Gocan, M. Stammler, and M. Imhof, “Improvement of postmenopausal depressive and anxiety symptoms after treatment with isoflavones derived from red clover extracts,” Maturitas, vol. 65, no. 3, pp. 258–261, 2010.
- L. A. Hidalgo, P. A. Chedraui, N. Morocho, S. Ross, and G. S. Miguel, “The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: a randomized, double-blind, placebo-controlled study,” Gynecological Endocrinology, vol. 21, no. 5, pp. 257–264, 2005.
- P. Chedraui, L. Hidalgo, G. S. Miguel, N. Morocho, and S. Ross, “Red clover extract (MF11RCE) supplementation and postmenopausal vaginal and sexual health,” International Journal of Gynecology and Obstetrics, vol. 95, no. 3, pp. 296–297, 2006.
- M. M. Terzic, J. Dotlic, S. Maricic, T. Mihailovic, and B. Tosic-Race, “Influence of red clover-derived isoflavones on serum lipid profile in postmenopausal women,” Journal of Obstetrics and Gynaecology Research, vol. 35, no. 6, pp. 1091–1095, 2009.
- J. E. Blümel, C. Castelo-Branco, P. A. Chedraui et al., “Patients' and clinicians' attitudes after the Women's Health Initiative study,” Menopause, vol. 11, no. 1, pp. 57–61, 2004.
- B. Ettinger, D. Grady, A. N. A. Tosteson, A. Pressman, and J. L. Macer, “Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy,” Obstetrics and Gynecology, vol. 102, no. 6, pp. 1225–1232, 2003.
- M. A. Schonberg and C. C. Wee, “Menopausal symptom management and prevention counseling after the Women's Health Initiative among women seen in an internal medicine practice,” Journal of Women's Health, vol. 14, no. 6, pp. 507–514, 2005.
- R. J. Miksicek, “Commonly occurring plant flavonoids have estrogenic activity,” Molecular Pharmacology, vol. 44, no. 1, pp. 37–43, 1993.
- R. J. Miksicek, “Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor,” Journal of Steroid Biochemistry and Molecular Biology, vol. 49, no. 2-3, pp. 153–160, 1994.
- E. Dornstauder, E. Jisa, I. Unterrieder, L. Krenn, W. Kubelka, and A. Jungbauer, “Estrogenic activity of two standardized red clover extracts (Menoflavon®) intended for large scale use in hormone replacement therapy,” Journal of Steroid Biochemistry and Molecular Biology, vol. 78, no. 1, pp. 67–75, 2001.
- J. T. Coon, M. H. Pittler, and E. Ernst, “Trifolium pratense isoflavones in the treatment of menopausal hot flushes: a systematic review and meta-analysis,” Phytomedicine, vol. 14, no. 2-3, pp. 153–159, 2007.
- P. Chedraui, G. S. Miguel, L. Hidalgo, N. Morocho, and S. Ross, “Effect of Trifolium pratense-derived isoflavones on the lipid profile of postmenopausal women with increased body mass index,” Gynecological Endocrinology, vol. 24, no. 11, pp. 620–624, 2008.
- S. Stevenson and J. Thornton, “Effect of estrogens on skin aging and the potential role of SERMs,” Clinical Interventions in Aging, vol. 2, no. 3, pp. 283–297, 2007.
- R. Paus and G. Cotsarelis, “The biology of hair follicles,” The New England Journal of Medicine, vol. 341, no. 7, pp. 491–497, 1999.
- M. J. Thornton, L. D. Nelson, A. H. Taylor, M. P. Birch, I. Laing, and A. G. Messenger, “The modulation of aromatase and estrogen receptor alpha in cultured human dermal papilla cells by dexamethasone: a novel mechanism for selective action of estrogen via estrogen receptor beta?” Journal of Investigative Dermatology, vol. 126, no. 9, pp. 2010–2018, 2006.
- M. P. Philpott, D. A. Sanders, and T. Kealey, “Effects of insulin and insulin-like growth factors on cultured human hair follicles: IGF-I at physiologic concentrations is an important regulator of hair follicle growth in vitro,” Journal of Investigative Dermatology, vol. 102, no. 6, pp. 857–861, 1994.
- D. M. Klotz, S. C. Hewitt, K. S. Korach, and R. P. Diaugustine, “Activation of a uterine insulin-like growth factor I signaling pathway by clinical and environmental estrogens: requirement of estrogen receptor-α,” Endocrinology, vol. 141, no. 9, pp. 3430–3439, 2000.
- J. Zhao, N. Harada, H. Kurihara, N. Nakagata, and K. Okajima, “Dietary isoflavone increases insulin-like growth factor-I production, thereby promoting hair growth in mice,” Journal of Nutritional Biochemistry, vol. 22, no. 3, pp. 227–233, 2011.
- R. R. Torgerson, “Burning mouth syndrome,” Dermatologic Therapy, vol. 23, no. 3, pp. 291–298, 2010.
- A. Forabosco, M. Criscuolo, G. Coukos et al., “Efficacy of hormone replacement therapy in postmenopausal women with oral discomfort,” Oral Surgery Oral Medicine and Oral Pathology, vol. 73, no. 5, pp. 570–574, 1992.
- R. Leimola-Virtanen, H. Helenius, and M. Laine, “Hormone replacement therapy and some salivary antimicrobial factors in post- and perimenopausal women,” Maturitas, vol. 27, no. 2, pp. 145–151, 1997.
- R. W. Wardrop, J. Hailes, H. Burger, and P. C. Reade, “Oral discomfort at menopause,” Oral Surgery Oral Medicine and Oral Pathology, vol. 67, no. 5, pp. 535–540, 1989.
- H. Välimaa, S. Savolainen, T. Soukka et al., “Estrogen receptor-β is the predominant estrogen receptor subtype in human oral epithelium and salivary glands,” Journal of Endocrinology, vol. 180, no. 1, pp. 55–62, 2004.
- C. M. Philpott, D. C. Wild, C. R. Wolstensholme, and G. E. Murty, “The presence of ovarian hormone receptors in the nasal mucosa and their relationship to nasal symptoms,” Rhinology, vol. 46, no. 3, pp. 221–225, 2008.
- K. Tsukahara, H. Nakagawa, S. Moriwaki et al., “Ovariectomy is sufficient to accelerate spontaneous skin ageing and to stimulate ultraviolet irradiation-induced photoageing of murine skin,” British Journal of Dermatology, vol. 151, no. 5, pp. 984–994, 2004.
- P. G. Sator, J. B. Schmidt, M. O. Sator, J. C. Huber, and H. Hönigsmann, “The influence of hormone replacement therapy on skin ageing: a pilot study,” Maturitas, vol. 39, no. 1, pp. 43–55, 2001.
- T. J. Phillips, Z. Demircay, and M. Sahu, “Hormonal effects on skin aging,” Clinics in Geriatric Medicine, vol. 17, no. 4, pp. 661–672, 2001.
- R. M. Brand and J. L. Jendrzejewski, “Topical treatment with (-)-epigallocatechin-3-gallate and genistein after a single UV exposure can reduce skin damage,” Journal of Dermatological Science, vol. 50, no. 1, pp. 69–72, 2008.
- S. Widyarini, N. Spinks, A. J. Husband, and V. E. Reeve, “Isoflavonoid compounds from red clover (Trifolium pratense) protect from inflammation and immune suppression induced by UV radiation,” Photochemistry and Photobiology, vol. 74, no. 3, pp. 465–470, 2001.
- E. Emmerson, L. Campbell, G. S. Ashcroft, and M. J. Hardman, “The phytoestrogen genistein promotes wound healing by multiple independent mechanisms,” Molecular and Cellular Endocrinology, vol. 321, no. 2, pp. 184–193, 2010.
- A. Thielemann, W. Wuttke, M. Wuttke, and D. Seidlova-Wuttke, “Comparison of urodynamic effects of phytoestrogens equol, puerarin and genistein with these of estradiol 17β in ovariectomized rats,” Experimental Gerontology, vol. 45, no. 2, pp. 129–137, 2010.
- I. U. Ahmad, J. D. Forman, F. H. Sarkar et al., “Soy isoflavones in conjunction with radiation therapy in patients with prostate cancer,” Nutrition and Cancer, vol. 62, no. 7, pp. 996–1000, 2010.
- C. del Giorno, A. M. da Fonseca, V. R. Bagnoli, J. S. de Assis, J. M. Soares Jr., and E. C. Baracat, “Effects of Trifolium pratense on the climacteric and sexual symptoms in postmenopause,” Revista da Associação Médica Brasileira, vol. 56, no. 5, pp. 558–562, 2010.